|
Name: Betaprodine
Type: Opioid analgesic
AKA: N/A
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
Betaprodine is a synthetic opioid developed in the mid-20th century. It is part of the prodine family of opioids, which were explored for their analgesic properties. Betaprodine saw limited use in medical practice, primarily due to the availability of other more effective opioids. It remains of interest in the study of synthetic opioid pharmacology.
|
|
V. Legal Information
Betaprodine is a synthetic opioid not widely regulated or scheduled under major drug control laws. Its status varies by country and may fall under general regulations for opioids if used for illicit purposes. In the US, it could be controlled under analog acts if deemed similar to Schedule I or II opioids. The trend towards tighter controls on synthetic opioids reflects concerns about abuse and addiction.
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Betaprodine, a potent synthetic opioid, is used for pain management. As a downer, it provides significant analgesia and sedation. Short-term effects include pain relief and euphoria, while long-term use may lead to severe addiction and respiratory depression. Overdose risks include life-threatening respiratory failure. Safe use requires careful dosing due to its high potency. Recent findings emphasize its effectiveness for pain management but also highlight significant risks of misuse and dependence.  |
|
VII. Psychological Effects
Betaprodine, a synthetic opioid, acts on opioid receptors to provide pain relief and euphoria. Psychological effects include mood elevation and potential cognitive impairment with long-term use. Risks include dependence and significant mental health issues. Research focuses on its safety profile and potential for abuse.
 |
|
VIII. Culture
Betaprodine, a synthetic opioid, has limited historical and cultural impact compared to more prominent opioids. Developed in the mid-20th century, it has primarily been used in medical settings for pain management. Its cultural relevance is minimal, but it is part of the broader narrative of opioid use and the ongoing search for effective analgesics. The substance highlights the complexities of opioid pharmacotherapy and the balance between providing pain relief and preventing misuse. Betaprodine’s role in the opioid discourse is one of many substances contributing to the challenges and advancements in pain management.
 |